Invest in Vision Research

Jump to Section

Give Smarter: Crypto, Stocks and Donor Advised Funds (DAFs) –
Donations that Maximize Impact

Avoid capital gains while funding research for treatments and cures for blinding diseases.

I Want to Donate         I'm Advising a Client

Choose Your Smartest Giving Strategy

  • Fast, secure blockchain transfers

    Donate Crypto

  • Simple transfer from your brokerage

    Donate Stock

  • Immediate tax benefit, distribute over time

    Donate DAF

Donate by December 31, 2025 – This is your last year before new IRS limits take effect. Starting January 1, 2026, itemizers face a 0.5% AGI deduction floor, non-itemizers can only deduct $1,000–$2,000 for cash gifts, and high-income donors see deduction values drop from 37% to 35%.

Disclaimer: The Foundation Fighting Blindness does not provide, and is not attempting to provide, legal, tax, or financial advice. Prospective donors should consult with a licensed tax professional or financial advisor to determine how a contribution may affect their individual circumstances.

Powered by The Giving Block

We've partnered with The Giving Block, the leading nonprofit crypto donation platform trusted by 1,500+ organizations. Your donation is protected by institutional-grade security, multi-signature wallets, and blockchain verification.

  • Bank-level encryption
  • Cold storage security
  • SOC 2 Type II certified

78 Cents of Every Dollar Goes to Our Mission

We're one of the most efficient nonprofits in medical research. When you give, you're directly funding scientists, trials, and treatments—not overhead. Your impact is maximized.

Global Mission. Global Impact. 

The Foundation partnered with ClearView Healthcare Partners to evaluate the impact of its funding and resources since 2005 on the clinical understanding and development of novel therapies for inherited retinal diseases (IRDs). Below are some key takeaways.

  • The Foundation has played a major role in the development of 88% of treatments in clinical trials for the leading retinal diseases.
  • Since 2005, projects funded by the Foundation have helped to identify 40% of the genes that cause blinding diseases.
  • More than 10% of people with blinding diseases are registered in the Foundation’s My Retina Tracker® Registry – the largest retinal disease patient database connecting people to relevant clinical trials.
  • Foundation-led natural history studies have helped to identify additional measures used to determine the success of clinical trials – including one that led to the first FDA-approved gene therapy for the eye or any inherited disease, LUXTURNA®.

Why Your Gift Matters

Accelerating Clinical Trials
There are currently 50+ clinical trials for blinding diseases—more than ever in history. Your donation helps recruit patients, support trial sites, and speed the path to FDA approval for new treatments.

Free Genetic Testing
We provide no-cost genetic testing through our My Retina Tracker® Genetic Testing Program, helping families understand their diagnosis and connect to clinical trials. Over 40,000 people have received answers about their vision loss.

Supporting Affected Families
The Foundation provides resources, education, and community for families navigating vision loss. We’re here for the 1 in 53 people globally living with vision loss.

Urgent Mission
Blinding diseases like retinitis pigmentosa and Stargardt disease are progressive—every day matters. People all over the world are losing vision right now. Your gift today funds the research that could save their sight tomorrow.

Thank you for supporting our mission!